Philip Sussman

Philip Sussman Email and Phone Number

Managing Partner at The Channel Group, LLC @ The Channel Group, LLC
new york, new york, united states
Philip Sussman's Location
New York, New York, United States, United States
Philip Sussman's Contact Details
About Philip Sussman

Senior-level biotechnology business development managerPharmaceutical alliances and drug candidate in-licensingAchieved over $100 million in funding from pharmaceutical company partnersCFO responsibilities in private and public companiesSpecialties: Life science, biotechnology, and pharmaceutical company businesss development. Financial transactions, including private financings and IPO.

Philip Sussman's Current Company Details
The Channel Group, LLC

The Channel Group, Llc

View
Managing Partner at The Channel Group, LLC
new york, new york, united states
Website:
thechannelgroup.com
Employees:
7
Philip Sussman Work Experience Details
  • The Channel Group, Llc
    Managing Partner
    The Channel Group, Llc Sep 2004 - Present
    Venture development and management for life science companies
    View
  • Biomed Transition Partners
    Managing Partner
    Biomed Transition Partners 2009 - Present
    BioMed Transition Partners and its team of experienced industry executives assist the Board of Directors and management of biomedical companies by providing guidance, leadership, and hands-on management for the development and implementation of strategies that are designed to stabilize companies in transition, and ultimately advance and realize shareholder value.
    View
  • Perosphere Inc.
    Vice President & Cfo
    Perosphere Inc. Jun 2011 - Present
    Danbury, Ct
    Perosphere's lead drug candidate is a reversal agent for new oral anticoagulants and the heparins.
  • Thar Pharmaceuticals, Inc.
    Board Of Directors
    Thar Pharmaceuticals, Inc. 2008 - Present
    Thar has proprietary drug candidates under development as well as an underlying platform technology for creating drug candidates that have composition of matter patent protection and that are eligible for approval via the FDA's 505(b)(2) regulatory pathway. Thar starts with a drug that is already on the market that could be improved in some way. Thar has developed an oral solid dose form of a cancer drug that is currently available only in an intravenous formulation. Thar has also developed a oral solid dose treatment for acute pain that has an onset of action of approximately 15 minutes, starting from a oral solid dose drug currently prescribed for chronic pain whose onset of action is approximately one hour.
  • Lesanne Life Sciences, Llc
    Board Of Directors
    Lesanne Life Sciences, Llc 2006 - Present
    Lesanne Life Sciences is a stroke diagnostics company that is developing a proprietary protein biomarker for the rapid diagnosis of CNS ischemia resulting from stroke, transient ischemic attacks ("TIAs"), lacunar infarcts, traumatic brain injury ("TBI"), myocardial infarction, and coronary artery bypass graft ("CABG") surgery.
    View
  • Perlegen Sciences, Inc.
    Vp Business Development
    Perlegen Sciences, Inc. Jan 2002 - Sep 2004
    Established research collaborations with biotechnology companies (Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, Eli Lilly, AstraZeneca) and CFO responsibilities
    View
  • Memory Pharmaceuticals Corporation
    Evp, Corporate Development
    Memory Pharmaceuticals Corporation 1999 - 2001
    Corporate development through partnerships, in-licensing, and M&A
    View
  • Cadus Pharmaceutical Corporation
    Svp Finance And Business Development And Cfo
    Cadus Pharmaceutical Corporation 1993 - 1999
  • Ciba-Geigy Pharmaceuticals
    Director Of Business Development & Strategy
    Ciba-Geigy Pharmaceuticals 1990 - 1993

Philip Sussman Skills

Biotechnology Lifesciences Corporate Development Venture Capital Strategy Pharmaceutical Industry Mergers And Acquisitions Business Development Licensing Commercialization Start Ups Life Sciences Entrepreneurship Private Placements Biopharmaceuticals Patents Cancer Drug Development Strategic Partnerships Technology Transfer Fda

Philip Sussman Education Details

Frequently Asked Questions about Philip Sussman

What company does Philip Sussman work for?

Philip Sussman works for The Channel Group, Llc

What is Philip Sussman's role at the current company?

Philip Sussman's current role is Managing Partner at The Channel Group, LLC.

What is Philip Sussman's email address?

Philip Sussman's email address is p.****@****ere.com

What is Philip Sussman's direct phone number?

Philip Sussman's direct phone number is +121276*****

What schools did Philip Sussman attend?

Philip Sussman attended Massachusetts Institute Of Technology - Sloan School Of Management, Manhattan University, State University Of New York At Stony Brook.

What skills is Philip Sussman known for?

Philip Sussman has skills like Biotechnology, Lifesciences, Corporate Development, Venture Capital, Strategy, Pharmaceutical Industry, Mergers And Acquisitions, Business Development, Licensing, Commercialization, Start Ups, Life Sciences.

Who are Philip Sussman's colleagues?

Philip Sussman's colleagues are Allan Goldberg, Allan Goldberg.

Not the Philip Sussman you were looking for?

View similar profiles

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.